Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Document › Details

Evolva Holding S.A.. (10/26/17). "Press Release: Evolva Announces Final Terms of Proposed Capital Increase [Not for release in US, CA, JP or AU or any jurisdiction where unlawful]".

Organisations Organisation Evolva Holding SA (SIX: EVE)
  Group Evolva (Group)
  Organisation 2 Pictet Asset Management S.A.
  Group Pictet (Group)
Products Product industrial biotechnology
  Product 2 investment banking
Index terms Index term Evolva–SEVERAL: investment, 201710 capital increase CHF21.1m private placement to Pictet Asset Management + Cologny Advisors at CHF0.31/share
  Index term 2 Evolva–SEVERAL: investment, 201710 capital increase CHF65m discounted right offering
Persons Person Walker, Oliver (Evolva 201807– CEO before CFO before Sivantos + Nobel Biocare + Sonova + Stratec)
  Person 2 Verbraeken, Paul (Evolva 201105 Investor Relations Manager)

Record changed: 2017-11-03


Picture [iito] Männer Ballett 650x80px

More documents for Evolva (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnering Forum 2020 Digital Event CBPF2020 650x80

» top